|
| Home - Fachinformation zu Evenity 105 mg/1.17 ml - Änderungen - 23.06.2023 | |
| 10 Änderungen an Fachinfo Evenity 105 mg/1.17 ml |
-Alendronat/ Alendronat (%) Romosozumab/ Alendronat (%)- + Alendronat/ Alendronat (%) Romosozumab/ Alendronat (%)
-Alendronat/ Alendronat (%) Romosozumab/ Alendronat (%)- + Alendronat/ Alendronat (%) Romosozumab/ Alendronat (%)
-Placebo (%) Romosozumab (%)- + Placebo (%) Romosozumab (%)
-Placebo (%) Romosozumab (%)- + Placebo (%) Romosozumab (%)
-Februar 2023- +April 2023
|
|
|
